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Abstract: Introduction: The recent development of a vaccine that is highly effective against the
human papillomavirus (HPV) has been met with widespread clinical and public health professional
acceptance. However, social and societal barriers to vaccination may hamper public health efforts to
prevent HPV-mediated diseases. Although a few studies have evaluated knowledge or awareness of
HPV vaccination among dentists or dental educators, few studies have evaluated the acceptance,
knowledge and awareness of HPV vaccination among dental students and post-graduate dental
residents. The primary goal of this study is to evaluate survey responses regarding acceptance,
knowledge and awareness of HPV vaccination among dental students and post-graduate dental
residents. Methods: This study was a retrospective analysis of a previously administered and collected
questionnaire. The original protocol was reviewed by the UNLV Biomedical Institutional Research
Board (IRB) and was deemed excluded from IRB review (OPRS#0811-2911). Results: Two hundred
and ninety-three (N = 293) dental student and forty-one (N = 41) post-graduate dental resident
questionnaires were available for a total sample size of N = 334. In brief, although the majority of
dental students and residents agreed that vaccines are safe and effective, less than half of dental
students (37.5%) or dental residents (48.7%) had discussed the HPV vaccine with a physician or had
received the vaccine themselves. In addition, a significant percentage of dental students and residents
felt they did not have enough information regarding the HPV vaccine (25.6% and 26.8%, respectively)
or had significant concerns about the side effects (17.1%). Conclusions: The data suggest more specific
information in dental school microbiology and immunology courses might be needed to increase
awareness and knowledge of the safety and effectiveness of vaccines, including the HPV vaccine.
This enhanced education might also serve as a curricular focal point to answer questions regarding
vaccine-related side effects and provide a mechanism for answering important questions regarding
this vaccine.
Keywords: human papillomavirus (HPV); vaccination; dental student; post-graduate dental resident
1. Introduction
The recent development of a highly effective vaccine against the human papillomavirus (HPV) has
been met with widespread clinical and public health interest and awareness based on scientific and lay
literature reports of its effectiveness and resulting reductions in associated cancer risk [1–4]. Systematic
reviews of randomized controlled trials (RCT) revealed strong antibody responses from two- and
three-dose vaccinations that have resulted in a significant reduction in the incidence of external genital
lesions and will likely result in long-term reduction in the incidence of high-risk cervical cancers and
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other HPV-mediated pathologies [5–7]. Recent systematic reviews and meta-analyses have revealed
compelling evidence of substantial reductions in HPV-specific infections in geographic areas with high
vaccination coverage, which will likely facilitate both direct clinical protection and more far-reaching
effects involving herd immunity within those communities [8,9].
However, in spite of these positive reports of HPV vaccine effectiveness, social and societal barriers
to vaccination may hamper public health efforts to prevent HPV-mediated diseases [10]. For example,
the challenge of increasing awareness, knowledge and compliance among boys and young men has
been particularly difficult as described by low participation rates since HPV has been viewed as a
pathogen primarily affecting women [11]. In addition, cultural beliefs and religious barriers based
on pre-marital sexual relations bans may also contribute to vaccine hesitancy among some specific
sub-populations that may harbor negative views regarding the topic of preventing sexually transmitted
infections [12]. Finally, the debunked myths and misconceptions regarding a link between vaccination
and childhood autism and other pediatric pathologies may still be pervasive among a significant
proportion of the population [13,14].
Although a few studies have evaluated knowledge or awareness of HPV vaccination among
practicing dentists or dental educators, it is unclear whether this information receives sufficient
emphasis in dental education to mold student views on vaccination that lead to their implementation
by students when they enter dental practice. Few studies have evaluated the awareness, knowledge and
acceptance of HPV vaccination among dental students and post-graduate residents [15,16]. The few
studies to date that have evaluated dental students specifically, have found deficiencies in both
knowledge and awareness that may be addressed through changes to the dental curriculum [17,18].
In fact, recent evidence has suggested that HPV-specific immunization training may be sufficient to
increase student knowledge and increase the likelihood of recommending HPV immunization among
dental hygiene students [19].
Based upon this information, the primary goal of this study is to evaluate dental student and
post-graduate resident awareness, knowledge and acceptance of HPV vaccination during a curricular
module devoted to immunization practices and HPV-specific vaccination.
2. Methods
2.1. Study Approval
The original protocol was reviewed by the UNLV Biomedical Institutional Research Board (IRB)
and was deemed excluded from IRB review (OPRS#0811-2911) November 12, 2008. Informed consent
was waived pursuant to the exemption to human subjects research under the Basic HHS Policy for
Protection of Human Research Subjects, (46.101) Subpart A (b) regarding IRB exemption for research
involving the use of education tests (cognitive, diagnostic, aptitude, achievement) in which the subjects
cannot be identified directly or through identifiers.
In brief, this study was a retrospective analysis of previously administered and collected student
responses. All enrolled dental students (n = 312) and post-graduate residents (n = 48) were asked
to complete a voluntary questionnaire, based upon a previously validated HPV vaccine awareness,
knowledge, perceptions and clinical practice survey discussed within the context of the required
Microbiology and Immunology course session focused on HPV and HPV vaccination [20].
Students were then placed into small groups of four and asked to pick one group of four questions
(Questions 3–6 regarding general vaccine safety and efficacy or Questions 14–17 regarding HPV vaccine
specifically) and find evidence-based information to support their answers. Each student would
take one of the four selected questions and find peer-reviewed articles to support (or refute) their
answers. The students then answered questions on a separate survey regarding how and where they
found this peer-reviewed or evidence-based information (information literacy skills). Neither the
HPV questionnaire or information literacy survey had any identifying information regarding the
respondents. At the completion of this exercise, students were allowed to voluntarily turn in either the
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HPV questionnaire, the information literacy survey or both. The information from the literacy survey
will be reviewed and published separately.
2.2. Questionnaire
The full questionnaire consisted of n = 17 total questions, divided between two sections. The first
section consisted of eight non-specific vaccine related questions assessing general knowledge, awareness,
perceptions and clinical practice guidelines. Four possible responses were available (Disagree, Neutral,
Agree, Not applicable). These questions included:
1. Vaccines are necessary to protect public health
2. There are too many required vaccines
3. Vaccines are generally safe
4. Vaccination can make you sick
5. Some vaccines are dangerous
6. Vaccines are generally effective
7. I follow the vaccine guidelines for myself
8. I adhere to the vaccine guidelines for my family The second section was comprised of nine
HPV-specific questions, which included:
9. I am aware of a vaccine for human papillomavirus (HPV)
10. HPV vaccination is important for me
11. HPV vaccination is important for (my) spouse/partner
12. HPV vaccination is important for (my) daughter(s)
13. HPV vaccination is important for (my) son(s)
14. I have discussed HPV vaccination with a doctor
15. I do not have enough information about the HPV vaccine
16. I am concerned about possible HPV vaccine side effects
17. I have already received the HPV vaccine
2.3. Statistical Analysis
Compliance with IRB and Informed Consent exemption required that no demographic or other
personal information could be collected at the time of the questionnaire collection, therefore no
summary statistics or analysis for these participants and the corresponding responses can be provided.
All questionnaire responses were transcribed in an Excel spreadsheet and descriptive statistics for
the percentage of responses from each question were reported. Differences in responses between
dental (DMD-level) students and post-graduate residents were analyzed using Chi square analysis
and on-line software from GraphPad (San Diego, CA, USA).
3. Results
The voluntary questionnaire was administered to all enrolled dental (DMD) students (n = 312).
Almost three hundred students completed this questionnaire, yielding an overall response rate of
93.9% (n = 293/312). The overall demographic breakdown of the overall student population was
approximately 55% male and 45% female (Table 1), which was not significantly different from the DMD
survey respondents, p = 0.7504. The racial and ethnic background of these students was approximately
half White/Caucasian (49.4%) and half non-White minorities (50.6%), including 39.1% Asians and 8.7%
Hispanics. These percentages were also not significantly different from the DMD survey respondents,
p = 0.5692.
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Table 1. DMD student population demographics.
Demographics DMD StudentPopulation
DMD Survey
Respondents Statistical Analysis
Sex
Male 55.4% (n = 173/312) 54.9% (n = 161/293) χ2 = 0.101, d.f. = 1
Female 44.6% (n = 139/312) 45.1% (n = 132/293) p = 0.7504
Race/Ethnicity
White 49.4% (n = 154) 48.5% (n = 242/293) χ2 = 0.324, d.f. = 1
Non-White (Minority) 50.6% (n = 158) 51.5% (n = 151/293) p = 0.5692
Asian 39.1% (n = 122)
Hispanic 8.7% (n = 27)
Other 2.9% (n = 9)
The voluntary questionnaire was also administered to all post-graduate dental (Pediatric,
Orthodontic) residents (n = 48). Forty-one residents completed this questionnaire, yielding an overall
response rate of 85.4% (n = 41/48). The overall demographic breakdown of the overall post-graduate
resident population was approximately 48% male and 52% female (Table 2), which was not significantly
different from the survey respondents, p = 0.6128. The racial and ethnic background of these students
is approximately half White/Caucasian (46.3%) and half non-White minorities (54.2%), exclusively
Asian. These percentages were also not significantly different from the survey respondents, p = 0.7512.
Table 2. Post-graduate resident demographics.
Demographics Post-GraduateResident Population
Post-Graduate Survey
Respondents Statistical Analysis
Sex
Male 47.9% (n = 23/48) 48.7% (n = 20/41) χ2 = 0.256, d.f. = 1
Female 52.1% (n = 25/48) 51.3% (n = 21/41) p = 0.6128
Race/Ethnicity
White 45.8% (n = 22/48) 46.3% (n = 19/41) χ2 = 0.101, d.f. = 1
Non-White (Minority) 54.2% (n = 26/48) 53.7% (n = 22/41) p = 0.7512
Asian 54.2% (n = 26/48) 53.7% (n = 22/41)
Hispanic N/A N/A
Other N/A N/A
To assess the knowledge and awareness of positive aspects of vaccinations, including vaccine
safety and efficacy, two specific questions from the questionnaire were evaluated: 3. Vaccines are
generally safe, and 6. Vaccination is generally effective (Figure 1). Although the level of agreement
was generally high, there was a significant difference in the percentage of DMD students that agreed
vaccines are generally safe (87.7%) versus the percentage that agreed vaccines are generally effective
(96.9%), p = 0.0001. The percentage of PGDR that agreed vaccines are generally safe (97.5%) was the
same as the percentage that agreed vaccines are generally effective (97.5%), p = 1.000.
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the percentage that agreed that some vaccines are dangerous (19.1%), p = 0.0001. Similarly, the 
percentage of PGDR that agreed vaccines can make you sick (34.1%) was higher and significantly 
different from the percentage who agreed that some vaccines are dangerous (9.8%), p = 0.0001. 
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Figure 1. Assessment of DMD and PGDR responses to specific questions: Vaccines are generally safe,
and Vaccination is generally effective. DMD students exhibited significantly lower percentages of
a reeing that vaccines are safe (87.7%) versus effective (96.9%) p = 0.0001, while no differences were
observed among the PGDR (97.5%), p = 1.000. Note: ** indicates statistically significant differences.
To assess the knowledge and awareness of negative aspects of vaccinations, including
vaccine-related illness and side effects, two specific questions from the questionnaire were evaluated:
4. Vaccines can make you sick, and 5. Some vaccines are dangerous (Figure 2). There was a significant
difference in the percentage of DMD students that agreed vaccines can make you sick (30.0%) and the
percentage that agreed that some vaccines are dangerous (19.1%), p = 0.0001. Similarly, the percentage
of PGDR that agreed vaccines can make you sick (34.1%) was higher and significantly different from the
percentage who agreed that some vaccines are dangerous (9.8%), p = 0.0001. Although the percentage of
DMD students and residents who agreed vaccines can make you sick was similar (30.0% versus 34.1%),
a significantly higher proportion of DMD students responded that some vaccines were dangerous
(19.1% versus 9.8%), p = 0.0001.
To assess specific aspects of HPV vaccination, two specific questions from the questionnaire
were evaluated: 14. I have discussed HPV vaccination with a doctor, and 17. I have received the
HPV vaccine (Figure 3). These data demonstrated that approximately one third (37.5%) of DMD
students had discussed the HPV vaccination with a doctor, with a similar percentage reporting having
received the HPV vaccination (37.7%), p = 0.8962. The percentage of PGDR that had discussed HPV
vaccination with a doctor (48.7%) was significantly higher—and much higher than the percentage of
DMD students—than the percentage that had received the HPV vaccination (41.4%), p = 0.0001.
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Finally, to assess the knowledge and awareness regarding HPV vaccinations, two additional
questions from the questionnaire were evaluated: 15. I do not have enough information about this
vaccine, and 16. I am concerned about possible HPV vaccine side effects (Figure 4). Analysis of
these data revealed that approximately one quarter of both the DMD and PGDR agreed they did
not have enough information regarding the HPV vaccine (25.6% and 26.8% respectively), which was
not significantly different, p = 0.396. In addition, the same percentage of both the DMD and PGDR
responders indicated they had concerns about possible HPV vaccine side effects (17.1%).Dent. J. 2020, 8, x FOR PEER REVIEW 8 of 11 
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Figure 4. Assessment of DMD and PGDR responses to specific HPV-related questions: I do not have
enough information about the HPV vaccine, and I am concerned about possible HPV vaccine side
effects. Both groups (DMD, PGDR) had similar percentages of agreeing they did not have enough
information regarding the HPV vaccine (25.6% and 26.8% respectively), p = 0.396. In addition, the same
percentage of both the DMD and PGDR responders indicated they had concerns about possible HPV
vaccine side effects (17.1%).
4. Discussion
The few previous studies that evaluated the awareness, knowledge and acceptance of HPV
vaccination among dental students and post-graduate residents found deficiencies in both knowledge
and awareness [15–18]. This study evaluated both dental student and post-graduate resident awareness,
knowledge and acceptance of HPV vaccination during a curricular module devoted to immunization
practices and HPV-specific vaccination and found noteworthy similarities and differences. For example,
although the majority in both groups agreed vaccines were effective (~97%), significantly fewer dental
students agreed they were safe. This provides support and confirmation of two previous studies that
found that dental provider concerns about safety and efficacy corresponded with reluctance to discuss
or recommend the HPV vaccine [21,22].
Moreover, the finding that nearly twice the percentage of dental students (approximately 20%)
compared with dental residents (approximately 10%) agreed that some vaccines were dangerous may
suggest that these concerns about vaccine safety, in general, may be more widespread and must be
addressed within the dental school curriculum [23,24]. Although one recent study found that further
education and training would improve willingness of dental providers to discuss and recommend
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HPV vaccination, previous work from the same group found dental student knowledge, awareness
and willingness may be more malleable than established dental providers [17,18,25].
The findings that higher percentages of PGDR had discussed or received the HPV vaccination
than DMD students may have several possible explanations. For example, the average age of a first year
dental student is approximately 25 years old, while the average age for a post-graduate dental resident
is closer to 30 years old—a difference of nearly five years that provides significant opportunities
to interact with other healthcare providers and vaccination experts [26,27]. In addition, a higher
proportion of PGDR may be married or partnered (likely also linked to age), which may increase the
likelihood of interactions with healthcare providers recommending vaccinations, including the HPV
vaccine [28,29].
This study also includes several limitations, which must also be considered. For example, this study
is a retrospective analysis of previously collected data from an educational seminar and was therefore
not designed specifically to collect demographic data and other variables that would allow for more in
depth and comprehensive analysis of the respondents. In addition, more recent studies have developed
and implemented psychometrically tested HPV surveys among college students, which may provide
more accurate and useful information for comparison [30–32].
5. Conclusions
Despite these limitations, the data suggest more specific information in dental school microbiology
and immunology courses might be needed to increase awareness and knowledge of the safety and
effectiveness of vaccines, more specifically including the HPV vaccine and the relationship to oral
cancer prevention. This enhanced education might also serve as a curricular focal point to answer
questions regarding vaccine-related side effects and provide a mechanism for answering important
questions regarding this vaccine.
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